Physician profile
John E Fellow
NPI 1497857460
$706.12
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $130 · 2021: $313.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $209.84 | 2021 | |
| Pacira Therapeutics, INC. | $135.99 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $100.94 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $71.62 | 2019 | |
| Scilex Pharmaceuticals INC. | $42.43 | 2019 | |
| Radius Health, INC. | $33.13 | 2019-2021 | |
| Amgen INC. | $29.85 | 2020 | |
| Allergan, INC. | $18.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.40 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.38 | 2020 | |
| Pfizer INC. | $15.20 | 2019 | |
| Janssen Biotech, INC. | $14.92 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fellow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.